<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-149014</identifier>
<setSpec>0210-0010</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Acute non-traumatic myelopathy in children and adolescents</dc:title>
<dc:description xml:lang="en">The term &#145;acute myelopathies&#146; &#150;referred to a spinal cord dysfunction&#150; represent a heterogeneous group of disorders with distinct etiologies, clinical and radiologic features, and prognoses. The objective of this review is to discuss the non-traumatic acute myelopathies. Acute myelopathy can be due to several causes as infective agents or inflammatory processes, such as in acute myelitis, compressive lesions, vascular lesions, etc. The clinical presentation is often dramatic with tetraparesis or paraparesis, sensory disturbances and bladder and/or bowel dysfunction. History and physical examination are used to localize the lesion to the root or specific level of the cord, which can guide imaging. Different syndromes are recognized: complete transverse lesion, central grey matter syndrome, anterior horn syndrome, anterior spinal artery syndrome, etc). The first priority is to rule out a compressive lesion. If a myelopathy is suspected, a gadolinium-enhanced MRI of the spinal cord should be obtained as soon as possible. If there is no structural lesion such as epidural blood or a spinal mass, then the presence or absence of spinal cord inflammation should be documented with a lumbar puncture. The absence of pleocytosis would lead to consideration of non inflammatory causes of myelopathy such as arteriovenous malformations, fibrocartilaginous embolism, or possibly early inflammatory myelopathy. In the presence of an inflammatory process (defined by gadolinium enhancement, cerebrospinal fluid pleocytosis, or elevated cerebrospinal fluid immunoglobulin index), one should determine whether there is an inflammatory or an infectious cause. Different virus, bacterias, parasites and fungi have to be considered as autoimmune and inflammatory diseases that involve the central nervous system (AU)</dc:description>
<dc:creator>Arroyo, Hugo A</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">El término &#145;mielopatías agudas&#146; se refiere a una disfunción de la médula espinal y representa un grupo heterogéneo de trastornos con distintas etiologías y características clínicas (imaginológicas y de pronóstico). El objetivo de esta revisión es tratar las mielopatías agudas no traumáticas. La mielopatía aguda puede deberse a varias causas, como agentes infecciosos o procesos inflamatorios, compresión y lesiones vasculares, entre otros. La presentación clínica es a menudo dramática con tetraparesia o paraparesia, alteraciones sensitivas y disfunción de la vejiga o del intestino. La historia y el examen físico se utilizan para localizar la lesión o el nivel específico de la médula, que puede guiar la solicitud de la imagen. La primera prioridad es descartar una lesión compresiva. Si se sospecha una mielopatía, debe obtenerse tan pronto como sea posible una resonancia magnética medular con gadolinio. Si no hay ninguna lesión estructural, entonces la presencia o ausencia de inflamación de la médula espinal debe documentarse con una punción lumbar. La ausencia de pleocitosis daría lugar a la consideración de causas no inflamatorias como malformaciones arteriovenosas, embolia fibrocartilaginosa o posiblemente el inicio de una mielopatía inflamatoria. En presencia de un proceso inflamatorio (realce con gadolinio, pleocitosis o elevado índice de inmunoglobulina en el líquido cefalorraquídeo), se deberá determinar si hay una inflamación o una causa infecciosa. Se tienen que considerar hongos, bacterias, parásitos y virus, así como enfermedades autoinmunes e inflamatorias que involucran al sistema nervioso central (AU)</dc:description>
<dc:source>Rev Neurol;57(supl.1): s129-s138, 6 sept. 2013. tab</dc:source>
<dc:identifier>ibc-149014</dc:identifier>
<dc:title xml:lang="es">Mielopatías agudas no traumáticas en niños y adolescentes</dc:title>
<dc:subject>^d13501^s22027</dc:subject>
<dc:subject>^d54668</dc:subject>
<dc:subject>^d7678^s22027</dc:subject>
<dc:subject>^d10333^s22027</dc:subject>
<dc:subject>^d13499^s22040</dc:subject>
<dc:subject>^d9380^s22016</dc:subject>
<dc:subject>^d29594^s22016</dc:subject>
<dc:subject>^d9379^s22016</dc:subject>
<dc:subject>^d13500^s22027</dc:subject>
<dc:subject>^d13501^s22067</dc:subject>
<dc:subject>^d30524^s22027</dc:subject>
<dc:subject>^d34318^s22027</dc:subject>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d34159^s22016</dc:subject>
<dc:subject>^d13501^s22016</dc:subject>
<dc:subject>^d29315</dc:subject>
<dc:subject>^d13503^s22016</dc:subject>
<dc:subject>^d2694</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d3965</dc:subject>
<dc:subject>^d7678^s22016</dc:subject>
<dc:subject>^d28561</dc:subject>
<dc:subject>^d34204^s22016</dc:subject>
<dc:subject>^d12219^s22027</dc:subject>
<dc:subject>^d9379^s22027</dc:subject>
<dc:subject>^d13500^s22016</dc:subject>
<dc:subject>^d13501^s22011</dc:subject>
<dc:subject>^d13501^s22012</dc:subject>
<dc:subject>^d13503^s22012</dc:subject>
<dc:type>article</dc:type>
<dc:date>201309</dc:date>
</metadata>
</record>
</ibecs-document>
